Search

Wang, Z., Z. Cheng, V. Cristofaro, J. Li, X. Xiao, P. Gomez, R. Ge, et al. 2021. Erratum. Inhibition of TNF-α Improves the Bladder Dysfunction That Is Associated With Type 2 Diabetes. Diabetes 2012;61:2134-2145.

Moreno, M. F., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2023. Conditional Survival Following Radical Cystectomy for Urothelial Carcinoma of the Bladder.

Morton, E., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. P. Kim, et al. 2023. Urothelial Carcinoma of the Bladder With Isolated Lymph Node Metastasis: Natural History and Outcomes Following Surgical Resection.

Wang, Z., X. Xiao, R. Ge, J. Li, C. W. Johnson, C. Rassoulian, and A. F. Olumi. 2023. Correction: Metformin Inhibits the Proliferation of Benign Prostatic Epithelial Cells.

Cheng, Bisheng, Qiong A Wang, Zean Li, Tianlong Luo, Junjia Xie, Sandeep Singh, Yong Luo, et al. 2025. “Induction of Ferroptosis in Prostate Cancer by CCDC719-13 via TRIM21-Mediated Ubiquitination of SLC7A11.”. Cell Death & Differentiation.

Gulati, R., B. Jiao, R. Al-Faouri, V. Sharma, S. Kaul, A. Fleishman, K. Wymer, et al. 2024. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging As First-Line Screening for Prostate Cancer : A Decision Model Analysis.

Perez-Londono, A., F. Ramos, A. Fleishman, S. Kaul, R. Korets, M. Johnson, A. F. Olumi, L. Tsai, and B. Gershman. 2025. Predicting Cancer Detection Rates from Multiparametric Prostate MRI Beyond the PI-RADS Classification System.

San Francisco, I. F., W. C. DeWolf, S. Rosen, M. Upton, and A. F. Olumi. 2003. Extended Prostate Needle Biopsy Improves Concordance of Gleason Grading Between Prostate Needle Biopsy and Radical Prostatectomy.

Kuten, A., A. Olumi, J. Goldsmith, R. A. Monahan-Earley, A. M. Dvorak, and E. M. Genega. 2004. Pathologic Quiz Case. A Symptomatic Renal Tumor. Juxtaglomerular Cell Tumor.

San Francisco, I. F., M. M. Regan, A. F. Olumi, and W. C. DeWolf. 2004. Percent of Cores Positive for Cancer Is a Better Preoperative Predictor of Cancer Recurrence After Radical Prostatectomy Than Prostate Specific Antigen.